Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer

Table 4 Analyses of 19 patients who had experienced IBTR

No.	Age	Histology of primary tumor	Subtype	RM	RT	Interval to IBTR (months)	Histology of IBTR	2nd recurrence	Interval to 2nd recurrences (mo.)	F/U duration (months)	Overall survival (months)
1	60	DCIS	ER +	Neg.	Not done	12	DCIS	none	N/A	41	80
2	26	DCIS	ER -	Pos.	Done	13	DCIS	none	N/A	126	128
3	52	DCIS	ER +	Pos.	Done	14	IDC	none	N/A	26	30
4	56	DCIS	ER -	Neg.	Not done	20	IDC	none	N/A	42	114
5	43	DCIS	ER -	Neg.	Done	47	IDC	none	N/A	52	52
6	31	Metaplastic	TN	Neg.	Done	14	Metaplastic, TN	none	N/A	30	30
7	45	IDC	TN	Neg.	Done	8	IDC, TN	lung	6	18	18 (dead)
8	48	IDC	TN	Neg.	Not done	14	IDC, TN		N/A	49	74
9	44	IDC	TN	Neg.	Done	15	IDC, TN		N/A	34	34
10	49	IDC	TN	Neg.	Done	16	IDC, TN	lung	9	35	35 (dead)
11	33	IDC	HER2	Neg.	Done	17	IDC, TN		N/A	62	69
12	36	IDC	Luminal	Neg.	Done	21	IDC, Luminal	bone	10	36	36
13	41	IDC	TN	Neg.	Done	22	IDC, HER-2	lung	15	38	42
14	65	IDC	Luminal	Neg.	Not done	30	IDC, Luminal		N/A	36	36
15	43	IDC	Luminal	Pos.	Not done	30	IDC, Luminal		N/A	38	47
16	44	IDC	TN	Neg.	Done	34	IDC, TN		N/A	52	52
17	51	IDC	Luminal	Neg.	Done	39	IDC, Luminal		N/A	49	60
18	48	IDC	TN	Neg.	Done	47	IDC, TN		N/A	63	77
19	39	IDC	HER2	Neg.	Done	52	IDC, HER2	lung	5	78	78 (dead)

ISSN: 1477-7819